Starboard has produced a 197-page deck to support its opposition to Bristol-Myers’ $74 bln offer for Celgene. Antony Currie and Rob Cyran highlight the presentation’s contradictions and misplaced micromanagement that undermine Starboard’s case.
![](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_upDIMIhe23YJyARDN7vINUhJnSZ9-ZA2xZzzsShpVbS7CcpesoNd7xHaaZj9KTD_IubNodqhqBlrvg51hZTzxof-f_-R5rjpfaIDJl88OWtO622YwHVCxbSosfm992F992RjWTzifeWAvfH_I=s0-d)
from Reuters Video: Breakingviews https://ift.tt/2FmPZsK
via IFTTT
from Reuters Video: Breakingviews https://ift.tt/2FmPZsK
via IFTTT
إرسال تعليق